BridgeBio Pharma Inc. (BBIO) Tops Q1 EPS by 3c

BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q1 EPS of ($0.88), $0.03 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $116.63 million versus the consensus estimate of $54.46 million.

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Rubio says Iran cannot charge tolls in Strait of Hormuz
• Craig-Hallum Upgrades Backblaze Inc (BLZE) to Buy